Blockade of neutral sphingomyelinase 2 exerts antitumor effect on metastatic castration resistant prostate cancer cells and promotes tumor regression when combined with Enzalutamide
Am J Cancer Res. 2024 Dec 15;14(12):5697-5716. doi: 10.62347/XXXA3182. eCollection 2024. ABSTRACT Prostate cancer (PCa) is the second leading cause of cancer-related deaths among American …